Hospital Pereyra Rossell, Montevideo Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2018
NCT03475121
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Centro Hospitalario Pereyra Rossell | Hospital Pereyra Rossell, Montevideo

Active Ingredients

Drugs in Phase 4 Trials (3)

diosmetine (1 trial)

hesperidin (1 trial)

ibuprofen (motrin) (1 trial)

Drugs in Phase 3 Trials (1)

topotecan (hycamtin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Retinoblastoma (Phase 3)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 4